![]() ![]() This lawsuit adds to the ongoing patent disputes among biotech companies concerning the technology utilized in the mRNA COVID-19 vaccines. However, neither company agreed to a license agreement. Promosome claimed that its president demonstrated the technology to a senior BioNTech scientist in 2015, Reuters noted. The lawsuits alleged that Promosome had discussions with Moderna between 20 regarding the licensing of the technology. And when the sequence used in its mRNA was revealed, it became clear that Moderna had taken Promosome's patented method. Years later, Moderna developed a COVID-19 vaccine generating billions in revenue. ![]() Promosome, the exclusive licensee of the ’179 patent, disclosed and taught its method of increasing protein expression to Moderna, but Moderna declined to license it.Īlso Read: US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma. The lawsuit claims that one of the scientists' significant contributions is a patented method for increasing mRNA protein expression, protected by U.S. The small biotechnology firm claims that its scientists, including Nobel laureate Gerald Edelman, who died in 2014, Vincent Mauro, and two colleagues from The Scripps Research Institute, developed a method used in the COVID-19 vaccines. ![]() Pfizer Inc (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA (mRNA) technology. ![]()
0 Comments
Leave a Reply. |